nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—NR3C2—Betamethasone—ankylosing spondylitis	0.104	0.206	CbGbCtD
Drospirenone—NR3C2—Prednisolone—ankylosing spondylitis	0.103	0.203	CbGbCtD
Drospirenone—PGR—Betamethasone—ankylosing spondylitis	0.0671	0.133	CbGbCtD
Drospirenone—NR3C2—Dexamethasone—ankylosing spondylitis	0.0604	0.12	CbGbCtD
Drospirenone—PGR—Dexamethasone—ankylosing spondylitis	0.039	0.0774	CbGbCtD
Drospirenone—BCHE—Triamcinolone—ankylosing spondylitis	0.0367	0.0727	CbGbCtD
Drospirenone—PTGS2—Triamcinolone—ankylosing spondylitis	0.0282	0.0559	CbGbCtD
Drospirenone—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0282	0.0559	CbGbCtD
Drospirenone—PTGS2—Betamethasone—ankylosing spondylitis	0.0242	0.048	CbGbCtD
Drospirenone—Potassium Canrenoate—Prednisone—ankylosing spondylitis	0.0234	0.0501	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisolone—ankylosing spondylitis	0.0229	0.0489	CrCrCtD
Drospirenone—Medrysone—Methylprednisolone—ankylosing spondylitis	0.0217	0.0464	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Methylprednisolone—ankylosing spondylitis	0.0209	0.0447	CrCrCtD
Drospirenone—Flurandrenolide—Methylprednisolone—ankylosing spondylitis	0.0202	0.0431	CrCrCtD
Drospirenone—Flurandrenolide—Betamethasone—ankylosing spondylitis	0.0199	0.0424	CrCrCtD
Drospirenone—Flurandrenolide—Dexamethasone—ankylosing spondylitis	0.0199	0.0424	CrCrCtD
Drospirenone—Medrysone—Prednisolone—ankylosing spondylitis	0.0193	0.0413	CrCrCtD
Drospirenone—Cortisone acetate—Methylprednisolone—ankylosing spondylitis	0.0183	0.0391	CrCrCtD
Drospirenone—Flurandrenolide—Prednisolone—ankylosing spondylitis	0.018	0.0384	CrCrCtD
Drospirenone—Testolactone—Methylprednisolone—ankylosing spondylitis	0.0177	0.0379	CrCrCtD
Drospirenone—Testolactone—Dexamethasone—ankylosing spondylitis	0.0175	0.0373	CrCrCtD
Drospirenone—Testolactone—Betamethasone—ankylosing spondylitis	0.0175	0.0373	CrCrCtD
Drospirenone—Testolactone—Triamcinolone—ankylosing spondylitis	0.0171	0.0365	CrCrCtD
Drospirenone—Cortisone acetate—Prednisone—ankylosing spondylitis	0.0167	0.0357	CrCrCtD
Drospirenone—Cortisone acetate—Prednisolone—ankylosing spondylitis	0.0163	0.0348	CrCrCtD
Drospirenone—Testolactone—Prednisone—ankylosing spondylitis	0.0162	0.0346	CrCrCtD
Drospirenone—Testolactone—Prednisolone—ankylosing spondylitis	0.0158	0.0338	CrCrCtD
Drospirenone—Progesterone—Prednisolone—ankylosing spondylitis	0.0142	0.0303	CrCrCtD
Drospirenone—Methyltestosterone—Prednisone—ankylosing spondylitis	0.0141	0.0302	CrCrCtD
Drospirenone—PTGS2—Dexamethasone—ankylosing spondylitis	0.0141	0.0279	CbGbCtD
Drospirenone—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.0138	0.0295	CrCrCtD
Drospirenone—Hydrocortisone—Methylprednisolone—ankylosing spondylitis	0.013	0.0277	CrCrCtD
Drospirenone—Hydrocortisone—Betamethasone—ankylosing spondylitis	0.0128	0.0273	CrCrCtD
Drospirenone—Hydrocortisone—Dexamethasone—ankylosing spondylitis	0.0128	0.0273	CrCrCtD
Drospirenone—Hydrocortisone—Triamcinolone—ankylosing spondylitis	0.0125	0.0266	CrCrCtD
Drospirenone—Testosterone—Prednisolone—ankylosing spondylitis	0.0123	0.0263	CrCrCtD
Drospirenone—Hydrocortisone—Prednisone—ankylosing spondylitis	0.0118	0.0253	CrCrCtD
Drospirenone—Hydrocortisone—Prednisolone—ankylosing spondylitis	0.0115	0.0247	CrCrCtD
Drospirenone—Infarction—Methylprednisolone—ankylosing spondylitis	0.00148	0.0579	CcSEcCtD
Drospirenone—Thromboembolic event—Methotrexate—ankylosing spondylitis	0.00101	0.0395	CcSEcCtD
Drospirenone—Embolism venous—Prednisolone—ankylosing spondylitis	0.000885	0.0347	CcSEcCtD
Drospirenone—Embolism venous—Triamcinolone—ankylosing spondylitis	0.000814	0.0319	CcSEcCtD
Drospirenone—Embolism venous—Methylprednisolone—ankylosing spondylitis	0.000812	0.0318	CcSEcCtD
Drospirenone—Embolism venous—Betamethasone—ankylosing spondylitis	0.000739	0.029	CcSEcCtD
Drospirenone—Embolism venous—Dexamethasone—ankylosing spondylitis	0.000739	0.029	CcSEcCtD
Drospirenone—Embolism—Prednisolone—ankylosing spondylitis	0.000696	0.0273	CcSEcCtD
Drospirenone—Embolism venous—Prednisone—ankylosing spondylitis	0.000643	0.0252	CcSEcCtD
Drospirenone—Embolism—Triamcinolone—ankylosing spondylitis	0.00064	0.0251	CcSEcCtD
Drospirenone—Embolism—Methylprednisolone—ankylosing spondylitis	0.000639	0.025	CcSEcCtD
Drospirenone—Loss of libido—Methotrexate—ankylosing spondylitis	0.000588	0.023	CcSEcCtD
Drospirenone—Embolism—Betamethasone—ankylosing spondylitis	0.000581	0.0228	CcSEcCtD
Drospirenone—Embolism—Dexamethasone—ankylosing spondylitis	0.000581	0.0228	CcSEcCtD
Drospirenone—Embolism—Prednisone—ankylosing spondylitis	0.000506	0.0198	CcSEcCtD
Drospirenone—Embolism—Methotrexate—ankylosing spondylitis	0.000423	0.0166	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000375	0.159	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000369	0.156	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000369	0.156	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000361	0.153	CbGdCrCtD
Drospirenone—Affect lability—Prednisolone—ankylosing spondylitis	0.000319	0.0125	CcSEcCtD
Drospirenone—Mood swings—Prednisolone—ankylosing spondylitis	0.000307	0.012	CcSEcCtD
Drospirenone—Affect lability—Triamcinolone—ankylosing spondylitis	0.000294	0.0115	CcSEcCtD
Drospirenone—Affect lability—Methylprednisolone—ankylosing spondylitis	0.000293	0.0115	CcSEcCtD
Drospirenone—Mood swings—Triamcinolone—ankylosing spondylitis	0.000283	0.0111	CcSEcCtD
Drospirenone—Mood swings—Methylprednisolone—ankylosing spondylitis	0.000282	0.011	CcSEcCtD
Drospirenone—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.000269	0.0105	CcSEcCtD
Drospirenone—Migraine—Betamethasone—ankylosing spondylitis	0.000266	0.0104	CcSEcCtD
Drospirenone—Migraine—Dexamethasone—ankylosing spondylitis	0.000266	0.0104	CcSEcCtD
Drospirenone—Affect lability—Betamethasone—ankylosing spondylitis	0.000266	0.0104	CcSEcCtD
Drospirenone—Affect lability—Dexamethasone—ankylosing spondylitis	0.000266	0.0104	CcSEcCtD
Drospirenone—Mood swings—Dexamethasone—ankylosing spondylitis	0.000256	0.01	CcSEcCtD
Drospirenone—Mood swings—Betamethasone—ankylosing spondylitis	0.000256	0.01	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.000246	0.00966	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.000245	0.0096	CcSEcCtD
Drospirenone—Affect lability—Prednisone—ankylosing spondylitis	0.000232	0.00909	CcSEcCtD
Drospirenone—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.000227	0.00888	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000226	0.0957	CbGdCrCtD
Drospirenone—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000226	0.00886	CcSEcCtD
Drospirenone—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000226	0.00884	CcSEcCtD
Drospirenone—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.000225	0.00883	CcSEcCtD
Drospirenone—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000225	0.00881	CcSEcCtD
Drospirenone—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000224	0.00879	CcSEcCtD
Drospirenone—Mood swings—Prednisone—ankylosing spondylitis	0.000223	0.00875	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000223	0.0942	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000223	0.0942	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000218	0.0921	CbGdCrCtD
Drospirenone—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000207	0.00813	CcSEcCtD
Drospirenone—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000207	0.00811	CcSEcCtD
Drospirenone—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000206	0.00809	CcSEcCtD
Drospirenone—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000206	0.00807	CcSEcCtD
Drospirenone—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000206	0.00806	CcSEcCtD
Drospirenone—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000206	0.00806	CcSEcCtD
Drospirenone—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000204	0.00801	CcSEcCtD
Drospirenone—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000204	0.00801	CcSEcCtD
Drospirenone—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.000201	0.00788	CcSEcCtD
Drospirenone—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000188	0.00738	CcSEcCtD
Drospirenone—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000188	0.00738	CcSEcCtD
Drospirenone—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000187	0.00734	CcSEcCtD
Drospirenone—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000187	0.00734	CcSEcCtD
Drospirenone—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000187	0.00732	CcSEcCtD
Drospirenone—Mood swings—Methotrexate—ankylosing spondylitis	0.000187	0.00731	CcSEcCtD
Drospirenone—Depression—Prednisone—ankylosing spondylitis	0.000181	0.0071	CcSEcCtD
Drospirenone—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00018	0.00707	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000179	0.00702	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000178	0.00698	CcSEcCtD
Drospirenone—Breast disorder—Methotrexate—ankylosing spondylitis	0.000178	0.00698	CcSEcCtD
Drospirenone—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00017	0.00666	CcSEcCtD
Drospirenone—Angiopathy—Betamethasone—ankylosing spondylitis	0.00017	0.00666	CcSEcCtD
Drospirenone—Haemoglobin—Prednisone—ankylosing spondylitis	0.000164	0.00642	CcSEcCtD
Drospirenone—Haemorrhage—Prednisone—ankylosing spondylitis	0.000163	0.00639	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000152	0.00594	CcSEcCtD
Drospirenone—Depression—Methotrexate—ankylosing spondylitis	0.000151	0.00593	CcSEcCtD
Drospirenone—Angiopathy—Prednisone—ankylosing spondylitis	0.000148	0.0058	CcSEcCtD
Drospirenone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000143	0.00562	CcSEcCtD
Drospirenone—Mental disorder—Prednisone—ankylosing spondylitis	0.000143	0.0056	CcSEcCtD
Drospirenone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000142	0.00557	CcSEcCtD
Drospirenone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000137	0.00537	CcSEcCtD
Drospirenone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000136	0.00534	CcSEcCtD
Drospirenone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00013	0.00511	CcSEcCtD
Drospirenone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00013	0.00511	CcSEcCtD
Drospirenone—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000129	0.00505	CcSEcCtD
Drospirenone—Angiopathy—Methotrexate—ankylosing spondylitis	0.000124	0.00485	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00012	0.0047	CcSEcCtD
Drospirenone—Mental disorder—Methotrexate—ankylosing spondylitis	0.000119	0.00468	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000115	0.0045	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000115	0.0045	CcSEcCtD
Drospirenone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000114	0.00445	CcSEcCtD
Drospirenone—Skin disorder—Prednisone—ankylosing spondylitis	0.000113	0.00441	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.0001	0.00393	CcSEcCtD
Drospirenone—Nervous system disorder—Methotrexate—ankylosing spondylitis	9.49e-05	0.00372	CcSEcCtD
Drospirenone—Nausea—Prednisolone—ankylosing spondylitis	9.47e-05	0.00371	CcSEcCtD
Drospirenone—Skin disorder—Methotrexate—ankylosing spondylitis	9.4e-05	0.00369	CcSEcCtD
Drospirenone—Nausea—Triamcinolone—ankylosing spondylitis	8.71e-05	0.00341	CcSEcCtD
Drospirenone—Nausea—Methylprednisolone—ankylosing spondylitis	8.69e-05	0.00341	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	8.36e-05	0.00328	CcSEcCtD
Drospirenone—Nausea—Betamethasone—ankylosing spondylitis	7.9e-05	0.0031	CcSEcCtD
Drospirenone—Nausea—Dexamethasone—ankylosing spondylitis	7.9e-05	0.0031	CcSEcCtD
Drospirenone—Nausea—Prednisone—ankylosing spondylitis	6.88e-05	0.0027	CcSEcCtD
Drospirenone—Nausea—Methotrexate—ankylosing spondylitis	5.75e-05	0.00225	CcSEcCtD
